Relative Bioavailability Study of 3 Different Delivery Vehicles of PF-07321332/Ritonavir Oral Powder Compared to the Commercial Tablet Formulation in Healthy Participants. A Phase 1, Open-label, Randomized, Single-Dose, Crossover Study to Estimate the Relative
Bioavailability of PF-07321332/Ritonavir Oral Powder in 3 Different Delivery Vehicles Relative to the Commercial PF-07321332/Ritonavir Tablets in Healthy Adult Participants Under Fasted Conditions.